Andreas Dieckmann

729 total citations
17 papers, 458 citations indexed

About

Andreas Dieckmann is a scholar working on Molecular Biology, Immunology and Ophthalmology. According to data from OpenAlex, Andreas Dieckmann has authored 17 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Ophthalmology. Recurrent topics in Andreas Dieckmann's work include RNA Interference and Gene Delivery (4 papers), Retinal Diseases and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). Andreas Dieckmann is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Retinal Diseases and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). Andreas Dieckmann collaborates with scholars based in Switzerland, Germany and Japan. Andreas Dieckmann's co-authors include Peter Angel, Ralph Mocikat, Stefan Zwilling, Petra Pfisterer, Thomas Wirth, Oliver Egeter, Martin Röcken, Kamran Ghoreschi, Marco Berrera and Peter Hagedorn and has published in prestigious journals such as Science, Nucleic Acids Research and Blood.

In The Last Decade

Andreas Dieckmann

17 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Dieckmann Switzerland 12 250 151 74 39 29 17 458
Jarosław Szary Poland 11 231 0.9× 77 0.5× 56 0.8× 48 1.2× 33 1.1× 19 425
Masahiro Shiba Japan 10 181 0.7× 102 0.7× 91 1.2× 88 2.3× 22 0.8× 37 448
Laura Lecce Australia 11 154 0.6× 119 0.8× 24 0.3× 33 0.8× 37 1.3× 20 312
Xiaofang Xiong China 12 165 0.7× 201 1.3× 98 1.3× 75 1.9× 16 0.6× 18 455
Man Jiang China 11 308 1.2× 88 0.6× 127 1.7× 54 1.4× 40 1.4× 27 563
Muhamad Ashraf Rostam Australia 8 263 1.1× 72 0.5× 60 0.8× 45 1.2× 13 0.4× 16 418
Ali Kuraishy United States 6 209 0.8× 155 1.0× 139 1.9× 75 1.9× 19 0.7× 7 474
H. Rosenbaum United States 12 240 1.0× 91 0.6× 79 1.1× 31 0.8× 26 0.9× 19 451
Gina Papadopoulou Greece 5 166 0.7× 163 1.1× 50 0.7× 90 2.3× 13 0.4× 7 376

Countries citing papers authored by Andreas Dieckmann

Since Specialization
Citations

This map shows the geographic impact of Andreas Dieckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Dieckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Dieckmann more than expected).

Fields of papers citing papers by Andreas Dieckmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Dieckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Dieckmann. The network helps show where Andreas Dieckmann may publish in the future.

Co-authorship network of co-authors of Andreas Dieckmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Dieckmann. A scholar is included among the top collaborators of Andreas Dieckmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Dieckmann. Andreas Dieckmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schofield, CJ, Randall Dere, Juliane Siebourg‐Polster, et al.. (2025). Proteomics approach identifies aqueous humor biomarkers in retinal diseases. Communications Medicine. 5(1). 134–134. 4 indexed citations
2.
Titz, Bjoern, Juliane Siebourg‐Polster, Vincent Lavergne, et al.. (2024). Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Translational Vision Science & Technology. 13(6). 17–17. 6 indexed citations
3.
Siebourg‐Polster, Juliane, Bjoern Titz, Zhiwen Jiang, et al.. (2023). Correlation of Aqueous, Vitreous, and Serum Protein Levels in Patients With Retinal Diseases. Translational Vision Science & Technology. 12(11). 9–9. 12 indexed citations
4.
Sostelly, Alexandre, Antoine Soubret, Christoph Bucher, et al.. (2019). Characterizing C5 Inhibition with the SMART-Ig Anti-hC5 Antibody Crovalimab in PNH Patients Using Free Available Paratopes. Blood. 134(Supplement_1). 1227–1227. 2 indexed citations
5.
Hagedorn, Peter, Marco Berrera, Andreas Dieckmann, et al.. (2018). Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice. Nucleic Acids Research. 46(11). 5366–5380. 41 indexed citations
6.
Dieckmann, Andreas, Peter Hagedorn, Marco Berrera, et al.. (2017). A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides. Molecular Therapy — Nucleic Acids. 10. 45–54. 51 indexed citations
7.
Sewing, Sabine, Adrian Roth, Michael Winter, et al.. (2017). Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia. PLoS ONE. 12(11). e0187574–e0187574. 38 indexed citations
8.
Arranz, Alicia, Konstantinos Papadakis, Andreas Dieckmann, et al.. (2012). Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomes. Journal of Controlled Release. 165(3). 163–172. 27 indexed citations
9.
Hanauer, Guido, et al.. (2012). The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia. 55(10). 2779–2788. 51 indexed citations
10.
Dieckmann, Andreas, Martin Kriebel, Emile Andriambeloson, Dan Ziegler, & Martin W. Elmlinger. (2011). Treatment with Actovegin® Improves Sensory Nerve Function and Pathology in Streptozotocin-Diabetic Rats via Mechanisms Involving Inhibition of PARP Activation. Experimental and Clinical Endocrinology & Diabetes. 120(3). 132–138. 24 indexed citations
11.
Andersson, Patrik, Katarina Gradin, Andreas Dieckmann, et al.. (2005). The dioxin/aryl hydrocarbon receptor mediates downregulation of osteopontin gene expression in a mouse model of gastric tumourigenesis. Oncogene. 24(19). 3216–3222. 18 indexed citations
12.
Kiss, Csaba, Jun Nishikawa, Andreas Dieckmann, et al.. (2002). Improved subtractive suppression hybridization combined with high density cDNA array screening identifies differentially expressed viral and cellular genes. Journal of Virological Methods. 107(2). 195–203. 8 indexed citations
13.
Doggett, Teresa A., John T. Swarthout, Stephen C. Jefcoat, et al.. (2002). Parathyroid Hormone Inhibits c-Jun N-Terminal Kinase Activity in Rat Osteoblastic Cells by a Protein Kinase A-Dependent Pathway. Endocrinology. 143(5). 1880–1888. 22 indexed citations
15.
Egeter, Oliver, Ralph Mocikat, Kamran Ghoreschi, Andreas Dieckmann, & Martin Röcken. (2000). Eradication of disseminated lymphomas with CpG-DNA activated T helper type 1 cells from nontransgenic mice.. PubMed. 60(6). 1515–20. 60 indexed citations
16.
Zwilling, Stefan, Andreas Dieckmann, Petra Pfisterer, Peter Angel, & Thomas Wirth. (1997). Inducible Expression and Phosphorylation of Coactivator BOB.1/OBF.1 in T Cells. Science. 277(5323). 221–225. 72 indexed citations
17.
Dieckmann, Andreas & B Krippl. (1994). The E1A transcriptional control region is efficiently activated in proliferating tissues of transgenic mice.. PubMed. 9(8). 2227–33. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026